Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 128 citing Lee: Meta-analysis: angiotensin-receptor blockers in chronic heart failure and high-risk.... (0.08 sec) 

Renin inhibition with aliskiren: where are we now, and where are we going?


M Azizi, R Webb, J Nussberger, NK … - Journal of hypertension, 2006 - journals.lww.com
With the development of aliskiren, blockade of the renin-angiotensin-aldosterone
system (RAAS) at the level of the interaction of renin with a substrate has
become a clinical reality. This review covers the specific features of the ...
Cited by 125 - Related articles - BL Direct - All 4 versions

Adverse effects of combination angiotensin II receptor blockers plus angiotensin-converting …

- sld.cu [PDF] 
CO Phillips, A Kashani, DK Ko, G Francis, … - Archives of internal medicine, 2007 - archinte.highwire.org
Methods MEDLINE (January 1966–December 2006) and Web sites for the National
Institute of Health Clinical Trials and the Food and Drug Administration were
searched for eligible RCTs that included 500 or more subjects, had a ...
Cited by 73 - Related articles - BL Direct - All 7 versions

2007 Guidelines for the management of arterial hypertension: The Task Force for the …


G Mancia, G De Backer, A Dominiczak, R … - Journal of hypertension, 2007 - journals.lww.com
Journal of Hypertension. Wolters Kluwer Health Logo. All Issues. ...
Cited by 77 - Related articles - All 8 versions

Angiotensin receptor blockers: therapeutic targets and cardiovascular protection


LM Ruilope, EA Rosei, GL Bakris, G Mancia, … - Blood pressure, 2005 - informahealthcare.com
In the prevention and treatment of cardiovascular disease, pharmacological
treatment strategies should have several aims: (i) in individuals without overt
cardiovascular disease, but with risk factors such as hypertension and/or ...
Cited by 53 - Related articles - BL Direct - All 6 versions

Angiotensin receptor blockers and risk of myocardial infarction: systematic review


MA McDonald, SH Simpson, JA Ezekowitz, G … - British Medical Journal, 2005 - bmj.com
You are seeing this message because your web browser does not support basic web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Objective To evaluate the ...
Cited by 59 - Related articles - BL Direct - All 17 versions

Role of Angiotensin II in Cardiovascular Disease--Therapeutic Implications of More Than a …


CM Ferrario - Journal of Renin-Angiotensin-Aldosterone System, 2006 - jra.sagepub.com
Page 1. http://jra.sagepub.com System Journal of Renin-Angiotensin-Aldosterone
DOI: 10.3317/jraas.2006.003 2006; 7; 3 J Renin Angiotensin ...
Cited by 46 - Related articles - BL Direct - All 10 versions

Angiotensin II receptor blockers and myocardial infarction: deeds and misdeeds


M Volpe, G Mancia, B Trimarco - Journal of hypertension, 2005 - journals.lww.com
Background: A recent editorial published by Verma and Strauss, entitled
'Angiotensin receptor blockers and myocardial infarction', examined, through a
partial analysis of individual trials, the use of angiotensin receptor ...
Cited by 37 - Related articles - BL Direct - All 5 versions

Safety and tolerability of angiotensin-converting enzyme inhibitor versus the combination of …


R Lakhdar, MH Al-Mallah, DE Lanfear - Journal of Cardiac Failure, 2008 - Elsevier
Nine trials that enrolled 18,160 patients met the inclusion criteria. A total of
9199 patients received combination therapy, and 8961 patients received an ACEI
only. Patients receiving combination therapy had an increased risk of ...
Cited by 19 - Related articles - All 17 versions

Cardiovascular drug therapy in elderly patients: specific age-related pharmacokinetic, …


AA Mangoni - Drugs &# 38; Aging, 2005 - ingentaconnect.com
Abstract. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . 913 1. Age-Related Changes in the Cardiovascular System . . ...
Cited by 13 - Related articles - BL Direct - All 7 versions

Angiotensin II antagonists–therapeutic benefits spanning the cardiovascular disease …


A Beltrame Ribeiro - Current Medical Research and Opinion®, 2005 - informahealthcare.com
Address for correspondence: Artur Beltrame Ribeiro, MD, PhD, Professor of
Medicine, Nephrology Division – UNIFESP – EPM, Hospital do Rim e
Hipertensão – Fundação Oswaldo Ramos, Rua Borges Lagoa, 960, ...
Cited by 13 - Related articles - BL Direct - All 7 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google